Industries
Biomanufacturing & Bio-industrial Production
What changes this industry: bio-solutions with evidence, technologies, suppliers and open money.
Overview of the industry
The production sector itself: contract development and manufacturing of biologics, advanced therapies and mRNA, small-batch scale-up centres, aseptic fill-finish, cell-free production and the consulting that takes a process from lab to plant. The equipment, instruments and software that biomanufacturing runs on are listed under Bioprocess equipment.
What it replaces 0
No graded substitution linked yet.
Technologies 19
| AI bioprocess optimization as SaaS Cloud/SaaS platforms applying machine learning to bioprocess development and manufacturing data to predict outcomes and optimize process parameters — a software … | Digital & IT |
| Amino-acid fermentation platform (continuous, recycling-based) Continuous fermentation with cell separation and recirculation, as in Ajinomoto's resource-recycling 'biocycle' — a fermentation route to L-tyrosine that … | Enzymes & biocatalysis |
| Automated cell culture systems Robotic and software platforms that automate the closed, GMP-grade cell culture and manufacturing steps behind cell and gene therapies — end-to-end automated … | Automation & robotics |
| Automated cell-preparation systems (ATMP) Closed, kit-based instruments that automate activation, transduction, expansion, wash and collection for cell therapies — replacing manual, labour-intensive … | Automation & robotics |
| Bioprocess scale-up consulting A genuinely thin, generic-professional-service category — dedicated bioprocess scale-up and technology-transfer consulting, distinct from CDMOs that manufacture … | Consulting & strategy |
| Bioproduction CDMO/CMO (biologics/ATMP/mRNA) Contract development and manufacturing organizations providing specialized infrastructure for advanced biopharmaceuticals. | Therapeutics & platforms |
| Cell-free systems & cell-free bioproduction Cell-free protein synthesis (CFPS) bypasses the living cell: ribosomes and translation factors in a reaction tube deliver the target protein in hours, not … | Foundries & design |
| Continuous biopharma manufacturing & next-generation facilities Feeding inputs in and removing outputs continuously instead of batch, moving from stainless steel to single-use bioreactors — at commercial scale (Genentech, … | Upstream & bioreactors |
| Continuous bioreactors & perfusion culture Bioreactors that feed fresh medium and remove product continuously while keeping the cells in — replacing batch manufacturing, commercially mature in perfusion … | Upstream & bioreactors |
| Fill-finish & aseptic biomanufacturing High-precision sterile filling of advanced biological drugs into final delivery formats using isolated robotic environments. | Therapeutics & platforms |
| Food-grade enzyme platforms Enzyme preparations made by fermentation with engineered production strains and used as processing aids in food — an established, regulated market: China's GB … | Enzymes & biocatalysis |
| High-cell-density culture systems Bioreactor hardware engineered to sustain far higher viable-cell densities than a conventional stirred tank — Repligen's XCell ATF perfusion system (100M+ … | Upstream & bioreactors |
| Intelligent fermentation platforms (AI-driven control) AI, IoT and advanced sensing that replace expert-driven, trial-and-error fermentation control — at commercial-pilot and early industrial stage, with validations … | Analytics & PAT |
| Large-scale protein purification systems Chromatography-based isolation of target proteins from complex mixtures, moving from batch Protein A capture to integrated and continuous trains — at … | Downstream purification |
| Local manufacturing for market access Contract development, technology-transfer and local-build services that establish in-country or regional biomanufacturing so a biologic or vaccine qualifies for … | Market access & commercial |
| Plasma-derived therapy manufacturing Medicines made from donated human plasma — collection, screening, fractionation, purification and fill-finish — a commercial-scale industry with a reported 20 % … | Therapeutics & platforms |
| Rare-sugar production (D-allulose) Enzymatic bioconversion of common sugars into monosaccharides that rarely occur in nature — rare-sugar syrup at commercial scale since 2012 and pure D-allulose … | Enzymes & biocatalysis |
| Scale-up centers for innovative biologic small-batch production Public-private manufacturing-innovation institutes that operate shared pilot- and demonstration-scale biomanufacturing facilities, letting a biologic developer … | Automation & robotics |
| Solid-dosage inline quality inspection (PAT) Sensors in a continuous tablet line that monitor material properties in real time instead of end-of-batch testing — real-time release approvals reported as … | Analytics & PAT |
Opportunities 6
| Tender | Czechia – Immunosuppressive agents – Selektivní Imunosupresiva - Eculizumab IV. Institut klinické a experimentální medicíny | Oct 20, 2026 4 days |
| Tender | Czechia – Immunosuppressive agents – Takrolimus 1x denně - LP ADVAGRAF Institut klinické a experimentální medicíny | Oct 20, 2026 4 days |
| Tender | Netherlands – Influenza vaccines – Trivalent Influenza Vaccines 2026 Rijksinstituut voor Volksgezondheid en Milieu (RIVM), RIVM | Oct 19, 2026 3 days |
| Grant | Development of cell-free protein synthesis platforms for discovery and/or production of biologicals European Commission | Apr 13, 2027 179 days |
| Grant | Fostering common farmland birds and mammals for resilient food production systems European Commission | Sep 22, 2027 341 days |
| Grant | Unleashing the potential of sustainable small-scale aquatic food production and recreational fisheries for … European Commission | Sep 23, 2027 342 days |